We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$23.3B
AUM Growth
-$265M
Cap. Flow
-$917M
Cap. Flow %
-3.93%
Top 10 Hldgs %
47.97%
Holding
197
New
23
Increased
32
Reduced
40
Closed
30

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$386M
2
AON icon
Aon
AON
+$368M
3
CTLT
CATALENT, INC.
CTLT
+$282M
4
CRM icon
Salesforce
CRM
+$266M
5
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$184M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$924M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$262M
3
CSGP icon
CoStar Group
CSGP
+$251M
4
INSP icon
Inspire Medical Systems
INSP
+$135M
5
WAB icon
Wabtec
WAB
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 29.33%
2 Technology 12.47%
3 Financials 9.64%
4 Industrials 5.44%
5 Communication Services 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TAL icon
76
TAL Education Group
TAL
$6.87B
$14.6M 0.06%
1,365,000
– –
ZYME icon
77
Zymeworks
ZYME
$1.67B
$13.6M 0.06%
1,601,000
– –
PCG icon
78
PG&E
PCG
$38.5B
$12.1M 0.05%
692,323
-579,319
-46% -$10.2M
GDS icon
79
GDS Holdings
GDS
$6.41B
$11.4M 0.05%
1,226,133
+516,133
+73% +$4.17M
ELEV
80
DELISTED
Elevation Oncology
ELEV
$9.72M 0.04%
3,598,418
-288,245
-7% -$1.09M
TWST icon
81
Twist Bioscience
TWST
$7.25B
$9.46M 0.04%
+192,000
New +$7.83M
RIO icon
82
Rio Tinto
RIO
$164B
$9.07M 0.04%
137,500
– –
VTYX
83
DELISTED
Ventyx Biosciences
VTYX
$7.32M 0.03%
3,170,000
– –
ROIV icon
84
Roivant Sciences
ROIV
$26.2B
$7.11M 0.03%
673,000
-225,600
-25% -$2.47M
TECX
85
Tectonic Therapeutic
TECX
$606M
$7.1M 0.03%
+431,010
New +$6.9M
BBOT
86
BridgeBio Oncology
BBOT
$747M
$6.13M 0.03%
600,000
– –
MTAL
87
DELISTED
Metals Acquisition
MTAL
$5.62M 0.02%
410,197
+252,697
+160% +$3.42M
CYTK icon
88
Cytokinetics
CYTK
$10.4B
$5.55M 0.02%
102,400
– –
MGX icon
89
Metagenomi Therapeutics
MGX
$46.3M
$5.48M 0.02%
1,343,201
– –
NVAX icon
90
Novavax
NVAX
$1.31B
$4.78M 0.02%
377,250
-753,750
-67% -$7.58M
RARE icon
91
Ultragenyx Pharmaceutical
RARE
$2.55B
$4.07M 0.02%
99,000
– –
PRME icon
92
Prime Medicine
PRME
$559M
$3.85M 0.02%
750,000
– –
COGT icon
93
Cogent Biosciences
COGT
$7.24B
$3.58M 0.02%
425,161
-36,839
-8% -$279K
IVCP
94
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$3.28M 0.01%
300,000
– –
BACA
95
DELISTED
Berenson Acquisition Corp. I
BACA
$3.04M 0.01%
285,715
– –
BDSX icon
96
Biodesix
BDSX
$248M
$2.87M 0.01%
+93,909
New +$2.68M
ARYD
97
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$2.29M 0.01%
200,000
– –
NRIX icon
98
Nurix Therapeutics
NRIX
$2.65B
$2.27M 0.01%
+108,799
New +$1.69M
AMLX icon
99
Amylyx Pharmaceuticals
AMLX
$2.54B
$2.19M 0.01%
1,150,221
– –
SMC
100
Summit Midstream
SMC
$419M
$2.07M 0.01%
58,214
– –
2 3
4
5 6

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Farallon Capital Management held 197 positions worth $23.3B, down 1.1% from $23.6B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Farallon Capital Management withdrew a net $917M in Q2 2024, closing 30 positions and reducing 40 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $924M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Walt Disney worth $356M.

  • Farallon Capital Management's largest Q2 2024 buy was Walt Disney: 3,582,168 shares worth $356M.
  • Farallon Capital Management added most to Aon in Q2 2024, an estimated $368M increase.
  • Farallon Capital Management's biggest Q2 2024 reduction was Alphabet (Google) Class C, cutting an estimated $262M.
  • Farallon Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $924M.
  • Farallon Capital Management's ten largest holdings make up 48% of its $23.3B portfolio in Q2 2024.
  • Farallon Capital Management opened 23 new positions and closed 30 in Q2 2024.
  • Farallon Capital Management's portfolio value fell 1.1% quarter-over-quarter to $23.3B.

Based on Farallon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.